[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "La Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 54, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 617224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 66, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 419420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 48, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 469420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 61, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 461099, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.1962, "open": 0.2005, "dayLow": 0.1955, "dayHigh": 0.2163, "regularMarketPreviousClose": 0.1962, "regularMarketOpen": 0.2005, "regularMarketDayLow": 0.1955, "regularMarketDayHigh": 0.2163, "payoutRatio": 0.0, "beta": -1.254, "trailingPE": 0.00041865977, "forwardPE": -0.11535817, "volume": 1768483, "regularMarketVolume": 1768483, "averageVolume": 2340016, "averageVolume10days": 3279890, "averageDailyVolume10Day": 3279890, "bid": 0.1435, "ask": 0.2459, "bidSize": 2, "askSize": 2, "marketCap": 107957, "fiftyTwoWeekLow": 0.183, "fiftyTwoWeekHigh": 11.9, "allTimeHigh": 480807.6, "allTimeLow": 0.183, "fiftyDayAverage": 0.97758, "twoHundredDayAverage": 1.466295, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3313005, "profitMargins": 0.0, "floatShares": 2987682, "sharesOutstanding": 536301, "sharesShort": 95933, "sharesShortPriorMonth": 5083, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.26540002, "heldPercentInsiders": 0.1088, "heldPercentInstitutions": 0.00964, "shortRatio": 0.62, "shortPercentOfFloat": 0.26540002, "impliedSharesOutstanding": 536301, "bookValue": 0.61, "priceToBook": 0.32999998, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -13156000, "trailingEps": 480.82, "forwardEps": -1.745, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": 0.294, "52WeekChange": -0.9819288, "SandP52WeekChange": 0.14987159, "quoteType": "EQUITY", "currentPrice": 0.2013, "targetHighPrice": 36.0, "targetLowPrice": 10.0, "targetMeanPrice": 23.0, "targetMedianPrice": 23.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 4055000, "totalCashPerShare": 1.241, "ebitda": -11263000, "totalDebt": 84000, "quickRatio": 1.47, "currentRatio": 1.702, "debtToEquity": 4.215, "returnOnAssets": -1.37523, "returnOnEquity": -3.97842, "freeCashflow": -5302875, "operatingCashflow": -9214000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fiftyTwoWeekHighChangePercent": -0.9830841, "fiftyTwoWeekChangePercent": -98.19289, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 480.82, "epsForward": -1.745, "epsCurrentYear": -5.885, "corporateActions": [{"header": "Reverse stock split", "message": "GRI announces 1 for 28 split effective Jan. 26, 2026", "meta": {"eventType": "SPLIT", "dateEpochMs": 1769403600000, "splitRatio": "1:28"}}], "postMarketTime": 1769215764, "regularMarketTime": 1769202001, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.59939, "regularMarketPrice": 0.2013, "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "marketState": "CLOSED", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "postMarketChangePercent": 4.321907, "postMarketPrice": 0.21, "postMarketChange": 0.008699998, "regularMarketChange": 0.0051, "regularMarketDayRange": "0.1955 - 0.2163", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2340016, "fiftyTwoWeekLowChange": 0.018299997, "fiftyTwoWeekLowChangePercent": 0.09999999, "fiftyTwoWeekRange": "0.183 - 11.9", "fiftyTwoWeekHighChange": -11.6987, "priceEpsCurrentYear": -0.034205604, "fiftyDayAverageChange": -0.77628005, "fiftyDayAverageChangePercent": -0.79408336, "twoHundredDayAverageChange": -1.264995, "twoHundredDayAverageChangePercent": -0.8627152, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Vallon Pharmaceuticals, Inc.", "nameChangeDate": "2026-01-23", "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]